AN EORTC GASTROINTESTINAL GROUP EVALUATION OF THE COMBINATION OF SEQUENTIAL METHOTREXATE AND 5-FLUOROURACIL, COMBINED WITH ADRIAMYCIN IN ADVANCED MEASURABLE GASTRIC-CANCER

被引:116
作者
WILS, J
BLEIBERG, H
DALESIO, O
BLIJHAM, G
MULDER, N
PLANTING, A
SPLINTER, T
DUEZ, N
机构
[1] LAURENTIUS HOSP, 6043 CV ??? 6043 CV, NETHERLANDS
[2] INST JULES BORDET, B-1000 BRUSSELS, BELGIUM
[3] UNIV HOSP ANNADAL, MAASTRICT, NETHERLANDS
[4] STATE UNIV GRONINGEN HOSP, 9700 RB GRONINGEN, NETHERLANDS
[5] ERASMUS UNIV, 3000 DR ROTTERDAM, NETHERLANDS
[6] EUROPEAN ORG RES TREATMENT CANC, CTR DATA, BRUSSELS, BELGIUM
[7] DR DANIEL DENHOED CANC CTR, ROTTERDAM, NETHERLANDS
关键词
D O I
10.1200/JCO.1986.4.12.1799
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1799 / 1803
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 1979, WHO HDB REPORTING RE, V48
[2]  
BERTINO JR, 1977, CANCER RES, V37, P327
[3]  
BROWMAN GP, 1984, CANCER TREAT REP, V68, P465
[4]   ENHANCED 5-FLUOROURACIL NUCLEOTIDE FORMATION AFTER METHOTREXATE ADMINISTRATION - EXPLANATION FOR DRUG SYNERGISM [J].
CADMAN, E ;
HEIMER, R ;
DAVIS, L .
SCIENCE, 1979, 205 (4411) :1135-1137
[5]   A COMPARISON OF 3 CHEMOTHERAPEUTIC REGIMENS IN THE TREATMENT OF ADVANCED PANCREATIC AND GASTRIC-CARCINOMA - FLUOROURACIL VS FLUOROURACIL AND DOXORUBICIN VS FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN [J].
CULLINAN, SA ;
MOERTEL, CG ;
FLEMING, TR ;
RUBIN, JR ;
KROOK, JE ;
EVERSON, LK ;
WINDSCHITL, HE ;
TWITO, DI ;
MARSCHKE, RF ;
FOLEY, JF ;
PFEIFLE, DM ;
BARLOW, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (14) :2061-2067
[6]   FAM THERAPY FOR ADVANCED GASTRIC-CANCER - AN IDEAL STANDARD [J].
CULLINAN, SA ;
MOERTEL, CG .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) :887-888
[7]  
CUNNINGHAM D, 1985, CANCER TREAT REP, V69, P927
[8]  
DOUGLASS HO, 1985, J CLIN ONCOL, V3, P888
[9]   AN EASTERN COOPERATIVE ONCOLOGY GROUP EVALUATION OF COMBINATIONS OF METHYL-CCNU, MITOMYCIN-C, ADRIAMYCIN, AND 5-FLUOROURACIL IN ADVANCED MEASURABLE GASTRIC-CANCER (EST-2277) [J].
DOUGLASS, HO ;
LAVIN, PT ;
GOUDSMIT, A ;
KLAASSEN, DJ ;
PAUL, AR .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (12) :1372-1381
[10]  
EVANS RM, 1981, CANCER RES, V41, P3288